Barriers and facilitators to ART adherence among ART non-adherence people living with HIV in Cameroon: A qualitative phenomenological study

被引:5
作者
Buh, Amos [1 ]
Deonandan, Raywat [1 ]
Gomes, James [1 ]
Krentel, Alison [2 ]
Oladimeji, Olanrewaju [3 ,4 ]
Yaya, Sanni [5 ,6 ]
机构
[1] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada
[2] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[3] Walter Sisulu Univ, Fac Hlth Sci, Dept Publ Hlth, Mthatha, Eastern Cape, South Africa
[4] Durban Univ Technol, Fac Hlth Sci, Durban, South Africa
[5] Univ Ottawa, Sch Int Dev & Global Studies, Ottawa, ON, Canada
[6] Imperial Coll London, George Inst Global Hlth, London, England
关键词
ANTIRETROVIRAL THERAPY ADHERENCE; RURAL SOUTH-AFRICA; INCOME COUNTRIES; LIFE EXPECTANCY; HIV/AIDS; IMPACT; DETERMINANTS; PERSPECTIVES; EXPERIENCES; ACCEPTANCE;
D O I
10.1371/journal.pone.0291487
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundAntiretroviral therapy (ART) needs to be taken for life with near perfect levels of adherence for it to be effective. Nonetheless, ART non-adherence is still observed in sub-Saharan African (SSA) countries such as Cameroon. The objective of this study was to assess the factors influencing non-adherence and or adherence among people living with HIV (PLWH) who have experienced non-adherence to ART in Cameroon.MethodsA descriptive qualitative study of PLWH who have experienced non-adherence with ART in Cameroon was conducted. Data were collected using in-depth interviews. Collected data were analyzed using the NVIVO 12 software.ResultsIn total, 43 participants participated in this study. The Southwest and Littoral regions each contributed 15 (34.88%) of participants, participants' mean age was 37.1 years (SD: 9.81) and majority 34 (82.93%) were females. ART adherence barriers include those related to patient (forgetfulness, business with other things, unwillingness to swallow drugs daily), medication (side effects), health service (arrogance of caregivers, occasional drug shortages at treatment centre, poor counseling of patient), stigma (fear of status disclosure), use of alternative treatment (traditional medicine, prayers and deliverance), resource limitation (limited food, limited finances), environmental/social (limited or no home support), and political instability (disruption of free circulation by ghost towns, roadblocks and gunshots in some regions). ART adherence facilitators include social support (family and peer support), aligning treatment with patient's daily routines (align ART with schedule of family members), use of reminders (phone alarm, sound of church bell), health sector/caregiver support (messages to patient, financial support, proper counseling), and patient's awareness of HIV status/ART knowledge (awareness of HIV positive status, Knowledge of ART benefits).ConclusionART adherence barriers in Cameroon include those related to patient, medication, health service, stigma, use of alternative treatment, resource limitation, environmental/social, and political instability. ART adherence facilitators include social support, aligning treatment with patient's daily routines, use of reminders, health sector/caregiver support, and patient's awareness of HIV status/ART knowledge. Given these barriers and facilitators, continuous information provision and consistent support both from patients' families and caregivers are needed to improve adherence among patients. Further studies including many regions and larger samples using both in-depth and focused group discussions as well as quantitative approaches are required to uncover the burden related to ART non-adherence.
引用
收藏
页数:17
相关论文
共 53 条
[1]  
Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
[2]   Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana [J].
Ankrah, Daniel N. A. ;
Koster, Ellen S. ;
Mantel-Teeuwisse, Aukje K. ;
Arhinful, Daniel K. ;
Agyepong, Irene A. ;
Lartey, Margaret .
PATIENT PREFERENCE AND ADHERENCE, 2016, 10 :329-337
[3]  
[Anonymous], 2018, HIV AIDS: Key Facts
[4]  
[Anonymous], 2014, March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infections: Recommendations for a public health approach
[5]   Adherence among children and young people living with HIV/AIDS: A systematic review of medication and comprehensive interventions [J].
Arrivillaga, Marcela ;
Martucci, Vanessa ;
Hoyos, Paula Andrea ;
Arango, Andrea .
VULNERABLE CHILDREN AND YOUTH STUDIES, 2013, 8 (04) :321-337
[6]   Facilitators and barriers to antiretroviral therapy adherence among HIV-positive adolescents living in Tanzania [J].
Audi, Cosette ;
Jahanpour, Ola ;
Antelman, Gretchen ;
Guay, Laura ;
Rutaihwa, Mastidia ;
van de Ven, Roland ;
Woelk, Godfrey ;
Baird, Sarah J. .
BMC PUBLIC HEALTH, 2021, 21 (01)
[7]  
Augustina O, 2019, Journal of AIDS and HIV Research, V11, P16, DOI 10.5897/jahr2018.0481
[8]  
Azia IN, BARRIERS ADHERENCE A, P8
[9]  
Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.18619, 10.3402/gha.v6i0.19570]
[10]   Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia [J].
Bezabhe, Woldesellassie M. ;
Chalmers, Leanne ;
Bereznicki, Luke R. ;
Peterson, Gregory M. ;
Bimirew, Mekides A. ;
Kassie, Desalew M. .
PLOS ONE, 2014, 9 (05)